OTC Markets EXMKT - Delayed Quote USD
Veradigm Inc. (MDRX)
4.2000
-0.1000
(-2.33%)
At close: May 13 at 1:46:54 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | 0.66 | 0.36 |
| Low Estimate | 0 | 0 | 0.33 | 0.26 |
| High Estimate | 0 | 0 | 1 | 0.46 |
| Year Ago EPS | -- | 0.18 | 0.49 | 0.66 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | -- | -- | 613.65M | 585.5M |
| Low Estimate | -- | -- | 603.2M | 584.6M |
| High Estimate | -- | -- | 624.09M | 586.4M |
| Year Ago Sales | -- | -- | 588M | 613.65M |
| Sales Growth (year/est) | -- | -- | 4.36% | -4.59% |
Earnings History
| Currency in USD | 3/31/2022 | 6/30/2022 | 9/30/2022 | 12/31/2022 |
|---|---|---|---|---|
| EPS Est. | 0.19 | 0.15 | 0.19 | 0.23 |
| EPS Actual | 0.13 | 0.18 | 0.23 | 0.22 |
| Difference | -0.06 | 0.03 | 0.04 | -0.01 |
| Surprise % | -32.76% | 21.62% | 23.77% | -2.25% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.66 | 0.36 |
| 7 Days Ago | 0 | 0 | 0.33 | 0.26 |
| 30 Days Ago | 0 | 0 | 0.43 | 0.45 |
| 60 Days Ago | 0 | 0 | 0.58 | 0.49 |
| 90 Days Ago | 0 | 0 | 0.66 | 0.72 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | -- | 1 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MDRX | -- | -- | 35.61% | -46.16% |
| S&P 500 | 13.17% | 3.05% | 8.05% | 13.75% |
Upgrades & Downgrades
| Maintains | Stephens & Co.: Equal-Weight to Equal-Weight | 1/31/2025 |
| Maintains | TD Cowen: Buy to Buy | 5/28/2024 |
| Downgrade | Deutsche Bank: Buy to Hold | 3/19/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 1/19/2024 |
| Initiated | Barclays: Equal-Weight | 1/3/2024 |
| Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 11/14/2023 |
Related Tickers
TBRG TruBridge, Inc.
24.95
-5.02%
NHIQ NantHealth, Inc.
0.0030
0.00%
SLP Simulations Plus, Inc.
31.10
+0.91%
NRC National Research Corporation
13.44
-2.96%
PHLT Performant Healthcare, Inc.
2.5800
0.00%
PHR Phreesia, Inc.
26.10
+0.19%
MGRX Mangoceuticals, Inc.
1.6400
-4.65%
AMWL American Well Corporation
7.60
+5.41%
HQY HealthEquity, Inc.
96.99
+0.34%
PINC Premier, Inc.
22.86
-0.65%